HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

myelopoietin

Myelopoietins (MPOs) constitute a family of engineered, chimeric molecules that bind and activate the IL-3 and G-CSF receptors on hematopoietic cells
Also Known As:
MPO (myelopoietin); SC 68420; SC-68420; myelopoietin SC-68420
Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Cantin, Jacques: 1 article (10/2002)
2. Chang, Jose: 1 article (10/2002)
3. Guevin, Raymond: 1 article (10/2002)
4. Lindsay, Mary-Ann: 1 article (10/2002)
5. Mackey, John: 1 article (10/2002)
6. Nabholtz, Jean-Marc: 1 article (10/2002)
7. Patel, Ravi: 1 article (10/2002)
8. Reese, David: 1 article (10/2002)
9. Riva, Alessandro: 1 article (10/2002)
10. Tkaczuk, Katherine: 1 article (10/2002)

Related Diseases

1. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Interleukin-3 Receptors (Interleukin 3 Receptor)
2. Granulocyte Colony-Stimulating Factor (G-CSF)
3. Doxorubicin (Adriamycin)
4. Cyclophosphamide (Cytoxan)
5. Docetaxel (Taxotere)
6. Filgrastim (Neupogen)
7. leridistim

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)